Baker McKenzie Advises Merit Medical on $140M Acquisition of View Point Medical to Expand Therapeutic Oncology Portfolio
"Baker McKenzie advised Merit Medical Systems on its acquisition of View Point Medical for about $140 million (USD 90M cash at closing plus two USD 25M deferred payments). The deal adds View Point’s FDA‑cleared OneMark Detection Imaging System and OneMark Tissue Markers to Merit’s therapeutic oncology portfolio, complementing its SCOUT platform. The transaction was led by M&A partner Lewis Popoff with a cross‑disciplinary Baker McKenzie team covering corporate/M&A, commercial, IP, FDA regulation, tax, benefits, and employment across U.S. offices."